Human medicines European public assessment report (EPAR): Fampyra, fampridine, Date of authorisation: 20/07/2011, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 3, Status: Authorised

Public statement on Esmya: Withdrawal of the marketing authorisation in the European Union

Opinion on medicine for use outside EU: Dapivirine Vaginal Ring 25 mg, dapivirine, Anti-HIV Agents, 23/07/2020 Positive opinion

Vaccine Monitoring Platform: List of EMA-funded studies

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 25, Status: Authorised

PSUSA00001858202409

Human medicines European public assessment report (EPAR): Evfraxy, denosumab, Date of authorisation: 30/06/2025, Status: Authorised

Evrysdi

Human medicines European public assessment report (EPAR): Votubia, everolimus, Date of authorisation: 02/09/2011, Revision: 15, Status: Authorised